Lista de obras - M. Maral Mouradian - Dominio Público Uruguay

Activation of the GDNF-inducible transcription factor (GIF) gene promoter by glucocorticoid and progesterone.

artículo científico publicado en 2009

Advances in gene therapy for movement disorders.

artículo científico publicado en 2008

Alpha-synuclein in Parkinson's disease: light from two new angles

artículo científico publicado en 2004

Alternate 5' exons in the rat brain-derived neurotrophic factor gene: differential patterns of expression across brain regions.

artículo científico publicado en 1994

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.

scholarly article by L Verhagen Metman et al published 1997 in Neurology

Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice

artículo científico publicado en 2014

BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent.

artículo científico publicado en 2001

Casein kinase II-mediated phosphorylation regulates alpha-synuclein/synphilin-1 interaction and inclusion body formation

artículo científico publicado en 2004

Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

artículo científico publicado en 2003

Characterization of a corticotropin releasing hormone responsive region in the murine proopiomelanocortin gene.

artículo científico publicado en 1993

Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

artículo científico publicado en 1994

Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.

artículo científico publicado en 2001

DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway ⬇️

artículo científico publicado el 5 de abril de 2012

DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex.

artículo científico publicado en 2010

Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.

artículo científico publicado en 1989

Degradation of alpha-synuclein by proteasome

scientific article published on 01 November 1999

Developmental expression of the zinc finger transcription factor DRRF (dopamine receptor regulating factor).

artículo científico publicado en 2002

Dopamine D-1 receptor agonist stimulation of prolactin secretion in man

artículo científico publicado en 1988

Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor

artículo científico publicado en 2001

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

artículo científico publicado en 2004

Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease

artículo científico publicado en 1996

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.

artículo científico publicado en 2005

Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model

artículo científico publicado en 2011

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

scientific article published on 01 January 2000

Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa

artículo científico publicado en 1994

Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications

artículo científico publicado en 1997

Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation

article by Yohan Oh et al published March 2011 in Brain Research

Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

artículo científico publicado en 2002

IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.

artículo científico publicado en 2002

In vivo regulation of glial cell line-derived neurotrophic factor-inducible transcription factor by kainic acid.

artículo científico publicado en 1999

Interaction of nuclear factors from young and old rat brain regions with regulatory sequences of the D2 dopamine receptor gene promoter.

artículo científico

Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications ⬇️

artículo científico publicado el 1 de enero de 1997

Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease

artículo científico publicado en 1987

Localization of CKII beta subunits in Lewy bodies of Parkinson's disease

artículo científico publicado en 2007

Localization of putative calcium-responsive regions in the rat BDNF gene ⬇️

artículo científico publicado el 15 de octubre de 1997

MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.

artículo científico publicado en 2014

MicroRNAs in Parkinson's disease.

artículo científico publicado en 2012

MicroRNAs in neurodegenerative diseases and their therapeutic potential.

artículo científico publicado en 2011

MicroRNAs in neurodegenerative disorders.

artículo científico publicado en 2010

Mitochondrial localization of DJ-1 leads to enhanced neuroprotection

artículo científico publicado en 2009

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

artículo científico publicado en 1997

Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.

artículo científico publicado en 1998

Neural cell line-specific regulatory DNA cassettes harboring the murine D1A dopamine receptor promoter.

artículo científico publicado en 1999

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.

artículo científico publicado en 2006

Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease ⬇️

artículo científico publicado el 1 de enero de 2013

Nucleic Acid-Based Therapeutics for Parkinson's Disease

scientific article published on 01 April 2019

PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival

artículo científico publicado en 1999

PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain

artículo científico publicado en 2000

Parkin accumulation in aggresomes due to proteasome impairment

artículo científico publicado en 2002

Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?

artículo científico publicado en 2014

Regulation of striatal dopamine receptors by corticosterone: an in vivo and in vitro study.

artículo científico publicado en 1999

Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates

scientific article published on 27 August 2019

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

artículo científico publicado en 1987

Spinal fluid CRF reduction in Alzheimer's disease

artículo científico publicado en 1986

Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements

artículo científico publicado en 2010

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB

article published in the Proceedings of the National Academy of Sciences of the United States of America

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease ⬇️

artículo científico publicado el 8 de febrero de 2012

The role of oxidative stress in Parkinson's disease

artículo científico publicado en 2013

Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription

artículo científico publicado en 2000

Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

artículo científico

Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA

artículo científico publicado en 2020

Two distinct promoters drive transcription of the human D1A dopamine receptor gene.

artículo científico publicado en 1996

Up-regulation of D1A dopamine receptor gene transcription by estrogen.

artículo científico publicado en 1999

Up-regulation of D3 dopamine receptor mRNA by neuroleptics

artículo científico publicado en 1996

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

artículo científico publicado en 1994

[3H]MK-801 binding in Alzheimer's disease.

artículo científico publicado en 1988

α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease ⬇️

artículo científico publicado el 21 de marzo de 2012

Lista de obras de M. Maral Mouradian

Activation of the GDNF-inducible transcription factor (GIF) gene promoter by glucocorticoid and progesterone.

Advances in gene therapy for movement disorders.

Alpha-synuclein in Parkinson's disease: light from two new angles

Alternate 5' exons in the rat brain-derived neurotrophic factor gene: differential patterns of expression across brain regions.

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.

Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice

BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent.

Casein kinase II-mediated phosphorylation regulates alpha-synuclein/synphilin-1 interaction and inclusion body formation

Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

Characterization of a corticotropin releasing hormone responsive region in the murine proopiomelanocortin gene.

Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.

DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway ⬇️

DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex.

Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.

Degradation of alpha-synuclein by proteasome

Developmental expression of the zinc finger transcription factor DRRF (dopamine receptor regulating factor).

Dopamine D-1 receptor agonist stimulation of prolactin secretion in man

Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.

Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa

Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications

Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation

Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.

In vivo regulation of glial cell line-derived neurotrophic factor-inducible transcription factor by kainic acid.

Interaction of nuclear factors from young and old rat brain regions with regulatory sequences of the D2 dopamine receptor gene promoter.

Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications ⬇️

Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease

Localization of CKII beta subunits in Lewy bodies of Parkinson's disease

Localization of putative calcium-responsive regions in the rat BDNF gene ⬇️

MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.

MicroRNAs in Parkinson's disease.

MicroRNAs in neurodegenerative diseases and their therapeutic potential.

MicroRNAs in neurodegenerative disorders.

Mitochondrial localization of DJ-1 leads to enhanced neuroprotection

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.

Neural cell line-specific regulatory DNA cassettes harboring the murine D1A dopamine receptor promoter.

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.

Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease ⬇️

Nucleic Acid-Based Therapeutics for Parkinson's Disease

PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival

PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain

Parkin accumulation in aggresomes due to proteasome impairment

Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?

Regulation of striatal dopamine receptors by corticosterone: an in vivo and in vitro study.

Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

Spinal fluid CRF reduction in Alzheimer's disease

Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements

Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease ⬇️

The role of oxidative stress in Parkinson's disease

Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription

Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA

Two distinct promoters drive transcription of the human D1A dopamine receptor gene.

Up-regulation of D1A dopamine receptor gene transcription by estrogen.

Up-regulation of D3 dopamine receptor mRNA by neuroleptics

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

[3H]MK-801 binding in Alzheimer's disease.

α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease ⬇️